Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

QSE/MCGS stock hub

QSE/MCGS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

QSE/MCGSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.6B

Qatar Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

QSE/MCGS

In the news

Latest news · QSE/MCGS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E23.2

P25 n/aP50 n/aP75 n/a

Trailing P/E20.6

P25 n/aP50 n/aP75 n/a

ROE7.5

P25 n/aP50 n/aP75 n/a

ROIC3.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All QSE/MCGS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

227

Groups with data

Currency

QAR

Showing 227 of 227 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Qatar
Country code	QA
Enterprise value	QAR 1.7B
Exchange	Qatar Stock Exchange
Financial currency	QAR
First seen	2026-05-10
Industry	Medical Care Facilities
Isin	QA0006929754
Last refreshed	2026-05-10
Market cap	QAR 1.6B
Price	QAR 5.57
Price currency	QAR
Sector	Healthcare
Sic	8060
Symbol	qse/MCGS
Website	https://www.medicare.com.qa

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.85%
EV Earnings	21.75x
EV/EBIT	26.35x
EV/EBITDA	18.55x
EV/FCF	47.03x
EV/Sales	3.29x
FCF yield	2.24%
Forward P/E	23.21x
P/B ratio	1.52x
P/E ratio	20.62x
P/S ratio	3.12x
PE Ratio10 Y	24.86x
PE Ratio3 Y	22.26x
PE Ratio5 Y	23.95x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	12.48%
EBITDA Margin	17.74%
FCF margin	6.99%
Gross margin	33.47%
Gross Profit	QAR 168.2M
Gross Profit Growth	-11.03%
Gross Profit Growth Q	-21.51%
Gross Profit Growth3 Y	-1.74%
Gross Profit Growth5 Y	-1.2%
Net Income	QAR 76M
Net Income Growth	26.57%
Net Income Growth Q	-41.99%
Net Income Growth Years	1%
Net Income Growth3 Y	-1.35%
Net Income Growth5 Y	-2.33%
Pretax Margin	15.12%
Profit Margin	15.12%
Profitable Years	18
ROA	2.82
Roa5y	3.34
ROCE	5.1
ROE	7.45
Roe5y	7.91
ROIC	3.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-0.2%
Cagr15y	10.47%
Cagr1y	27.39%
Cagr20y	8.24%
Cagr3y	1.61%
Cagr5y	-5.64%
Div CAGR10	-3.05%
Div CAGR3	0%
Div CAGR5	-2.52%
EPS Growth	26.57
EPS Growth Q	-42.36
EPS Growth Years	1
EPS Growth3 Y	-1.35
EPS Growth5 Y	-2.33
FCF Growth	-35.15%
FCF Growth Q	-68.46%
FCF Growth3 Y	-15.22%
FCF Growth5 Y	-11.06%
OCF Growth	-12.75%
OCF Growth Q	8.71%
OCF Growth10 Y	-4.34%
OCF Growth3 Y	-2.58%
OCF Growth5 Y	-3.69%
Revenue Growth	-3.99x
Revenue Growth Q	-10.33x
Revenue Growth Years	0x
Revenue Growth3 Y	1.05x
Revenue Growth5 Y	1.06x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	QAR 0.36
Assets	QAR 1.4B
Cash	QAR 64.5M
Current Assets	QAR 206.1M
Current Liabilities	QAR 153.4M
Debt	QAR 150M
Debt EBITDA	QAR 1.68
Debt Equity	QAR 0.15
Debt FCF	QAR 4.27
Equity	QAR 1B
Liabilities	QAR 353.3M
Long Term Assets	QAR 1.2B
Long Term Liabilities	QAR 199.9M
Net Cash	QAR -85.5M
Net Cash By Market Cap	QAR -5.46
Net Debt EBITDA	QAR 0.96
Net Debt Equity	QAR 0.08
Net Debt FCF	QAR 2.43
Tangible Book Value	QAR 1B
Tangible Book Value Per Share	QAR 3.66
WACC	5.3

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.34
Inventory Turnover	11.47
Net Working Capital	QAR 16.8M
Quick ratio	1.02
Working Capital	QAR 52.7M
Working Capital Turnover	QAR 6.82

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	11.11%
Dividend Growth Years	0%
Dividend per share	QAR 0.22
Dividend Years	15
Dividend Yield	3.95%
Ex Div Date	2026-04-01
Last Dividend	QAR 0.22
Payout Frequency	Annual
Payout Ratio	73.43%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-1.96%
1Y total return	27.36%
200-day SMA	6.13
3Y total return	4.91%
50-day SMA	5.37
50-day SMA vs 200-day SMA	50under200
5Y total return	-25.2%
All Time High	20.4
All Time High Change	-72.7%
All Time High Date	2015-07-26
All Time Low	0.68
All Time Low Change	725.19%
All Time Low Date	2009-03-03
ATR	0.13
Beta	0.28
Beta1y	0.17
Beta2y	0.22
Ch YTD	-16
High	5.62
High52	7.21
High52 Date	2025-09-23
High52ch	-22.78%
Low	5.56
Low52	4.5
Low52 Date	2025-06-02
Low52ch	23.78%
Ma50ch	3.69%
Price vs 200-day SMA	-9.09%
RSI	54.32
RSI Monthly	49.87
RSI Weekly	50.8
Sharpe ratio	0.83x
Sortino ratio	1.51
Total Return	3.95%
Tr YTD	-12.22
Tr15y	345.05%
Tr1m	8.22%
Tr1w	1%
Tr3m	-5.39%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	QAR 62.7M
Operating Income Growth	-24.06
Operating Income Growth Q	-48.52
Operating Income Growth3 Y	-5.23
Operating Income Growth5 Y	-4.3
Operating margin	12.48

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	-35,290,728
Shares Institutions	2.05%
Shares Out	281,441,000
Shares Qo Q	1.22%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	QAR 35.1M
Average Volume	972,442.3x
Bv Per Share	3.66
CAPEX	QAR -60M
Ch10y	-35.9
Ch15y	124.1
Ch1m	8.22
Ch1w	1
Ch1y	21.88
Ch20y	139.1
Ch3m	-9.46
Ch3y	-8.99
Ch5y	-40.1
Ch6m	-12.89
Change	0.13%
Change From Open	0.18
Close	5.56
Days Gap	0
Depreciation Amortization	26,399,027
Dollar Volume	3,933,444.9
Earnings Date	2026-04-21
EBIT	QAR 62.7M
EBITDA	QAR 89.1M
EPS	QAR 0.27
F Score	5
FCF	QAR 35.1M
FCF EV Yield	2.13x
FCF Per Share	QAR 0.12
Financing CF	-91,107,426
Fiscal Year End	December
Founded	1,995
Graham Number	4.71791
Graham Upside	-15.3
Investing CF	-20,392,805
Is Primary Listing	1
Last Earnings Date	2026-04-21
Last Report Date	2025-12-31
Last Split Date	2019-06-20
Last Split Type	Forward
Lynch Fair Value	QAR 1.35
Lynch Upside	-75.76
Ma150	6.12
Ma150ch	-8.93%
Ma20	5.52
Ma20ch	0.96%
Net CF	-16,340,242
Open	5.56
P FCF Ratio	44.6
P OCF Ratio	16.47
Position In Range	16.67
Ppne	1,075,037,550
Price Date	2026-05-07
Price EBITDA	QAR 17.59
Ptbv Ratio	1.52
Relative Volume	0.73x
Revenue	502,601,326x
Tr20y	386.83%
Tr6m	-8.97%
Volume	706,184
Z Score	3.39

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

QSE/MCGS dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3.9%

$0.22 annual per share

Payout ratio

+73.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-2.5%

0 consecutive years of growth

Total shareholder yield

+3.9%

Next ex-dividend date: 2026-04-01

Performance

QSE/MCGS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns QSE/MCGS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.1%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

QSE/MCGS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.3

Neutral momentum band

Price vs 200-day MA

-9.1%

50/200-day relationship not available

Beta (5Y)

0.28

Less volatile than the market

Sharpe ratio

0.83

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About QSE/MCGS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current qse/MCGS stock rating?

qse/MCGS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full qse/MCGS analysis?

The full report lives at /stocks/qse/MCGS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for qse/MCGS?

The latest report frames qse/MCGS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the qse/MCGS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.